Year in Review: Research News from 2014 in Non-Small Cell Lung Cancer

Year in Review: Research News from 2014 in Non-Small Cell Lung Cancer

After several years of developments in lung cancer treatment, more-targeted and more-individualized treatment for nonsmall cell lung cancer became a reality. Results from studies evaluating ALK-inhibitors continued to show promise in 2014 and initial studies exploring immunomodulatory approaches using anti-PD-1 antibodies demonstrated high response rates and slowed cancer progression in previously untreated stage IV NSCLC.

CancerConnect News coverage of advances in the management of lung cancer included the following key developments:

2014 FDA News in Lung Cancer

2014 Screening News

2014 Advances in Precision Medicine for Lung Cancer Patients

2014 NSCLC Research News

2015 Events:

Current Lung Cancer News

LEARNING MORE ABOUT LUNG CANCER

Knowledge is power. Are you facing a new diagnosis, recurrence, living with metastatic disease, or supporting a loved one through their cancer journey?

  • Sign up for monthly newsletters on lung cancer here.
  • Get the facts about lung cancer here.
  • Join ongoing discussions with other individuals affected by lung cancer in the CancerConnect private online support group here.
  • Follow CancerConnect on Facebook and Twitter.

Copyright © 2018 CancerConnect. All Rights Reserved.

Comments

Stories